Abstract

Physicians often face challenges in prescribing the most economical anti-cancer drugs due to a lack of comprehensive, up-to-date comparative information on drug costs. To analyze the variation in cost percentage among various brands of anti-cancer drugs available in the Indian market, this study is designed. For analysis of the costs of the anti-cancer drugs a Pharma Sahi Daam from March 2021 to September 2021 was used to collect study data. For every drug calculation was done to find the difference between the maximum and minimum costs. Similarly, it also done for cost ratio and variation of cost percentage. Among anti-cancer drugs, drug with highest cost is Bevacizumab 400 mg injection; 117625 and drug with lowest cost is temozolomide 20 mg, 100 mg, 250 mg capsule; 0.25. Among anticancer drugs cost ratio is highest for temozolomide (20 mg/100 mg/250 mg Capsule; 8407.192 and cost ratio is lowest for Bleomycin 15 IU injection; 1.002. Among anti-cancer drugs cost variation is highest for Temozolomide 20 mg/100 mg/250 mg capsule; 840619.2 and cost variation is lowest for Fulvestrant 250 mg injection; 40.3318. This study shows among anti-cancer drugs there is a high variation in prices, cost ratio and cost variation. Study may helpful for understanding price variation among anti-cancer drugs. It may useful to doctors to get knowledge regarding the variations of cost among drugs to choose prices which will be cheap to patient.